Emergent Biosolutions (Gaithersburg, US) has purchased US and Canadian rights to Kloxxado, adding to its opioid overdose ...
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) ...
The $50 million Patch Forward Prize, part of BARDA's Project NextGen initiative ... the platform can rapidly pivot to address pandemic or regional outbreaks of other strains.
GlobalData on MSN3d
$590m to Moderna from HHS for mRNA ‘flu vax developmentModerna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...
The $50 million Patch Forward Prize, part of BARDA's Project NextGen initiative ... Initially targeting drifted seasonal influenza strains, the platform can rapidly pivot to address pandemic or ...
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Emergent Biosolutions (EBS – Research Report), with a ...
Shionogi & Co. has been awarded a $375 million project agreement by the Biomedical Advanced Research and Development ...
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate ...
( MENAFN - The Arabian Post) Recognized for Advancing Growth Strategy & Technological Innovation ...
Currently, there is a significant unmet need to address shortcomings in preventative ... is subject to up to 12 options being exercised by BARDA in further support of the development of pre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback